The Current and Emerging Landscape of Pharmacotherapy for Neonatal Respiratory Distress Syndrome (NRDS)

Details

Activity Description / Statement of Need:

In this online, self-learning activity:

Neonatal respiratory distress syndrome (RDS) occurs in 10.1% of preterm infants born at 34 weeks’ gestational age (GA), corresponding to an over 40-fold increased risk as compared to their 39- to 40-week-GA counterparts. The risk decreases with increasing GA; at a GA of 37 weeks, the risk has fallen to just to just three times that of a full-term infants. Aside from premature birth, risk factors include: maternal gestational diabetes, male infant, and multiplets.

Target Audience:

The following healthcare professionals: neonatologists; physician assistants, nurse practitioners, nurses, and pharmacists who clinically encounter neonatal patients with RSD.

By the end of the session the participant will be able to:

• Identify the pathophysiology, clinical features, and strategies for diagnosis of neonatal RDS
• Review current and emerging options for the management of neonatal RDS
• Develop pre- and postnatal treatment plans for the prevention and management of neonatal RDS